As more states legalize marijuana, more physicians have begun recommending cannabis to their patients for the management of pain, nausea, anxiety, and loss of appetite. Recent literature also suggests that cannabis may be effective in treating other conditions. For example, the Federal Food and Drug Administration (FDA) recently approved a drug whose active ingredient is an extract from the marijuana plant, cannabidiol (CBD), for the treatment of a rare form of epilepsy. Some physicians would like to prescribe marijuana or marijuana extracts for hospital patients and have asked that these substances be added to the hospital formulary, but strictly speaking it that would require the breaking (or bending) of federal regulations.
Editor’s note: this blog post originally appeared on The Greeley Company’s website.
To view the rest of the post, click here.
News from our Partners
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
